Halozyme Therapeutics
HALO
#2478
Rank
A$8.98 B
Marketcap
$70.62
Share price
-15.40%
Change (1 day)
15.63%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$2.57 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are A$2.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.42 B-1.45%
2022-12-31A$2.45 B96.26%
2021-12-31A$1.25 B124.42%
2020-12-31A$0.55 B-17.63%
2019-12-31A$0.67 B149.29%
2018-12-31A$0.27 B-31.94%
2017-12-31A$0.39 B-2.15%
2016-12-31A$0.40 B114.08%
2015-12-31A$0.19 B25.11%
2014-12-31A$0.15 B11.53%
2013-12-31A$0.13 B65.22%
2012-12-31A$82.63 M54.45%
2011-12-31A$53.5 M-23.45%
2010-12-31A$69.89 M-10.62%
2009-12-31A$78.19 M-9.83%
2008-12-31A$86.72 M65.93%
2007-12-31A$52.26 M79.05%
2006-12-31A$29.18 M827.25%
2005-12-31A$3.14 M54.24%
2004-12-31A$2.04 M454.81%
2003-12-31A$0.36 M-66.03%
2002-12-31A$1.08 M16704.16%
2001-12-31A$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.03 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$94.80 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.78 B 1,017.14%๐Ÿ‡บ๐Ÿ‡ธ USA
A$196.34 B 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$94.12 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
A$167.27 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA